Form 4 for FBIO Fortress Biotech, Inc.
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-01 · accession 0001104659-24-000913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2024-01-01 | FBIO | Lorenz Kevin | Dir | A - Grant | $0.00 | +3,333 | 24.3K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.001 | 2024-01-01 | A | A | 3,333 | $0.00 | 24,304 | D | — | — | (F2) One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service. (F1) Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split. |